| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |